| Application no. and date | 16810152.5 (espacenet) (Federated) (European Patent Register), 20161118 | | Patent/reg. no. and date | DK/EP 3376857, 20210224 | | Publication date | 20180926 | | Priority no. and date | US 201562258181 P, 20151120, US 201662370430 P, 20160803 | | EP pub. no. and date |
EP 3376857 20180926 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | V342533DK00 | | Inventor | MURPHY, Andrew J., c/o Regeneron Pharmaceuticals Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US,
BUROVA, Elena, c/o Regeneron Pharmaceuticals Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US,
MUJICA, Alexander O., c/o Regeneron Pharmaceuticals Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A01K 67/027 (2006.01) , C07K 14/47 (2006.01) , C07K 14/705 (2006.01) | | Title | IKKE-HUMANE DYR, DER HAR ET HUMANISERET LYMFOCYT-AKTIVERINGSGEN 3 | | Int. application no. | US2016062733 | | Int. publication no. | WO2017087780 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
